GlassScriptPhysician profile
Jill Kaczmarek
NPI 1023095098
$314.34
in general payments reported to CMS, 2019-2025
11 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.03 · 2022: $32.97 · 2023: $30.50 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $47.58 | 2025 | Jardiance, Mounjaro |
| Organon LLC | $45.05 | 2025 | Nexplanon |
| Pfizer INC. | $37.32 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $30.51 | 2021-2022 | |
| Sanofi Pasteur INC. | $30.50 | 2023 | |
| Exact Sciences Corporation | $28.92 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $23.29 | 2025 | Shingrix |
| Abbvie INC. | $18.65 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.23 | 2025 | Airsupra |
| Kaleo, INC. | $18.05 | 2021 | |
| Dexcom, INC. | $16.24 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Kaczmarek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.